When I pull up a quote for Neuren, it shows a PE of 25 based upon EPS of 0.44 and a stock price of $11. The product of the EPS and the PE is $11. So someone in investor land is bestowing a PE of 25. Questions for the Board - is there any legitimacy to an EPS of 0.44? Is that past or projected earnings, and shouldn’t it be projected earnings? With Acadia announcing Q3 at or about November 2 along with projected Q4, what would the share price be based upon a forward looking PE of 25, and with whatever methodology is currently at play? Thank you in advance.
When I pull up a quote for Neuren, it shows a PE of 25 based...
-
- There are more pages in this discussion • 3,684 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.620(2.99%) |
Mkt cap ! $2.569B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $19.92 | $5.947M | 296.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $20.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.19 | 10 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |